Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bock

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Clinical Nephrology|June 19, 2010
Resistance management in chronic hepatitis B complicated by renal failureJ Wiegand, T Karlas, I Schiefke, et al.
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health|December 1, 2005
Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathyC-T Bock, K Klingel, S Aberle, et al.
Lancet (London, England)|June 20, 1992
No risk of diabetes after insulin-shock treatmentT Bock, C R Pedersen, K Josefsen, et al.
Bone Marrow Transplantation|September 1, 1996
Ex vivo manipulations of CD34+ peripheral blood progenitor cellsW Brugger, S Scheding, W Vogel, et al.
Diabetes, Obesity & Metabolism|October 9, 2007
Evaluation of beta-cell mass and function in the Göttingen minipigM O Larsen, B Rolin, K Raun, et al.
Klinische Wochenschrift|July 1, 1987
Increased thromboplastic potential in diabetes: a multifactorial phenomenonM M Landgraf-Leurs, T Ladik, B Smolka, et al.
Autoimmunity|March 27, 2001
Linomide does not prevent spontaneous autoimmune thyroiditis in NOD miceM L Hartoft-Nielsen, A K Rasmussen, A Kaas, et al.
Journal of Molecular Biology|March 13, 2001
Structural organization of the hepatitis B virus minichromosomeC T Bock, S Schwinn, S Locarnini, et al.
Diabetologia|October 20, 1999
Inhibition of insulin-specific autoreactive T-cells by sulphatide which is variably expressed in beta cellsK Buschard, N C Schloot, A Kaas, et al.
Diabetes Care|November 1, 1982
Crossover study with human insulin (recombinant DNA) in type I diabetic subjectsR Landgraf, S Kammerer, T Bock, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Clinical Nephrology|June 19, 2010
Resistance management in chronic hepatitis B complicated by renal failureJ Wiegand, T Karlas, I Schiefke, et al.
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health|December 1, 2005
Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathyC-T Bock, K Klingel, S Aberle, et al.
Lancet (London, England)|June 20, 1992
No risk of diabetes after insulin-shock treatmentT Bock, C R Pedersen, K Josefsen, et al.
Bone Marrow Transplantation|September 1, 1996
Ex vivo manipulations of CD34+ peripheral blood progenitor cellsW Brugger, S Scheding, W Vogel, et al.
Diabetes, Obesity & Metabolism|October 9, 2007
Evaluation of beta-cell mass and function in the Göttingen minipigM O Larsen, B Rolin, K Raun, et al.
Klinische Wochenschrift|July 1, 1987
Increased thromboplastic potential in diabetes: a multifactorial phenomenonM M Landgraf-Leurs, T Ladik, B Smolka, et al.
Autoimmunity|March 27, 2001
Linomide does not prevent spontaneous autoimmune thyroiditis in NOD miceM L Hartoft-Nielsen, A K Rasmussen, A Kaas, et al.
Journal of Molecular Biology|March 13, 2001
Structural organization of the hepatitis B virus minichromosomeC T Bock, S Schwinn, S Locarnini, et al.
Diabetologia|October 20, 1999
Inhibition of insulin-specific autoreactive T-cells by sulphatide which is variably expressed in beta cellsK Buschard, N C Schloot, A Kaas, et al.
Diabetes Care|November 1, 1982
Crossover study with human insulin (recombinant DNA) in type I diabetic subjectsR Landgraf, S Kammerer, T Bock, et al.
Pageof 9